Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Comintelli | COMINT | Dec 27, 2024 | 3.30 | -13.61 |
Compodium | COMPDM | Dec 27, 2024 | 5.65 | 0.00 |
Concejo B | CNCJOB | Dec 27, 2024 | 43.90 | 0.00 |
Condo Nordic Holding AB | CONDO | Dec 27, 2024 | 1.21 | +10.00 |
Consensus B | CAMB | Dec 27, 2024 | 9.64 | -5.49 |
Coor Service Management Holding | COOR | Dec 27, 2024 | 34.26 | +0.76 |
Corem Property Group A | COREA | Dec 27, 2024 | 6.70 | +2.29 |
Corem Property Group B | COREB | Dec 27, 2024 | 6.63 | +1.61 |
Corem Property Group D | CORED | Dec 27, 2024 | 245.00 | +0.82 |
Corem Property Group Pref | COREPREF | Dec 27, 2024 | 261.00 | +1.36 |
Corline Biomedical | CLBIO | Dec 27, 2024 | 8.86 | 0.00 |
Cortus Energy | CE | Dec 27, 2024 | 0.15 | -0.67 |
Creades A | CREDA | Dec 27, 2024 | 72.00 | +2.35 |
Creturner Group | CRET | Dec 27, 2024 | 0.24 | +5.29 |
Crown Energy | CRWN | Dec 27, 2024 | 0.56 | -3.42 |
Crunchfish | CFISH | Dec 27, 2024 | 1.20 | +6.19 |
CTEK | CTEK | Dec 27, 2024 | 14.00 | -0.57 |
CTT Systems | CTT | Dec 27, 2024 | 279.00 | +0.72 |
Curasight | CURAS | Dec 27, 2024 | 8.98 | +0.22 |
Cyber Security 1 | CYB1 | Dec 27, 2024 | 0.01 | +20.00 |
Cyclezyme AB | CYCLE | Dec 27, 2024 | 7.00 | -3.45 |
Dala Energi | DE | Dec 27, 2024 | 101.50 | 0.00 |
Dedicare B | DEDI | Dec 27, 2024 | 56.30 | +1.26 |
Desenio | DSNO | Dec 27, 2024 | 0.20 | -9.09 |
DevPort | DEVPB | Dec 27, 2024 | 27.50 | +1.85 |
Devyser Diagnostics | DVYSR | Dec 27, 2024 | 118.50 | -0.42 |
DexTech Medical | DEX | Dec 27, 2024 | 4.00 | -3.38 |
Diadrom Holding | DIAH | Dec 27, 2024 | 6.60 | -4.90 |
Diagonal Bio | DIABIO | Dec 27, 2024 | 0.02 | -22.50 |
Diamyd Medical B | DMYDB | Dec 27, 2024 | 17.18 | +3.87 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.